Amyloid deposition is decreasing in aging brains: an autopsy study of 1,599 older people

Neurology
Enikö KövariGabriel Gold

Abstract

To explore cohort effects on age- and Alzheimer disease (AD)-related neuropathologic changes. We compared amyloid deposition in autopsied cases aged 65 years and older who died between 1972 and 2006. We included consecutive cases for 1972-1975, 1980, 1985, 1990, 1995, and 2000-2006. We used linear regression models to assess period effects after adjustment for age, cognitive status, and neurofibrillary tangle (NFT) staging. We calculated amyloid/NFT stage ratios to account for possible changes in AD prevalence/severity over time. Mean amyloid stage was significantly related to year of death (p = 0.001) in the total population (1,599 cases, mean age 82 ± 8 years) and decreased 24%, from 1.88 ± 0.89 to 1.57 ± 0.81 (p < 0.0001), in 1,265 individuals without dementia. This decrease was particularly marked in the oldest age groups; people 85 years and older in 2006 had less amyloid deposition compared with those aged 75 to 84 years in 1972. Recent cohorts had lower amyloid deposition. The amyloid/NFT stage ratio decreased from 1.51 ± 0.74 to 0.99 ± 0.56 (p < 0.0001) in cases without dementia and from 0.74 ± 0.13 to 0.56 ± 0.21 (p = 0.0019) in individuals with dementia, confirming that more recent cases had less amyloid despite highe...Continue Reading

Citations

Feb 11, 2016·The New England Journal of Medicine·Claudia L SatizabalSudha Seshadri
Mar 5, 2016·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
Apr 23, 2016·Nature Reviews. Neurology·Ingmar Skoog
Jul 2, 2016·Journal of Neurosciences in Rural Practice·Sunil Kumar RainaAmit Bhardwaj
Jun 22, 2016·Revista clínica española·F Bermejo-ParejaA Villarejo-Galende
Feb 18, 2017·Nature Reviews. Neurology·Vincent C T MokLawrence K S Wong
Feb 11, 2015·Journal of the International Neuropsychological Society : JINS·Richard J CaselliYonas E Geda
Jan 11, 2018·Alzheimer Disease and Associated Disorders·Mary GanguliHugh C Hendrie
Aug 21, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Giovanni B FrisoniCraig Ritchie
Mar 8, 2017·Journal of Neural Transmission·Lauren WalkerJohannes Attems
Oct 12, 2018·Nature Reviews. Neuroscience·Roberto CabezaM Natasha Rajah
Jul 28, 2020·JAMA Network Open·David S Knopman
May 16, 2017·Journal of Neuropathology and Experimental Neurology·Jerzy WegielThomas Wisniewski
Jun 27, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Richard J CaselliGuojun Bu
Jul 7, 2020·Zeitschrift für Gerontologie und Geriatrie·Alexander Rösler, Renate Schnabel
Apr 4, 2021·International Journal of Clinical Practice·Audai A HayajnehEman S Alsatari
May 15, 2021·Nature Reviews. Disease Primers·David S KnopmanDavid T Jones

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.